Voxelotor Completed Phase 4 Trials for Sickle Cell Anemia Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT04581356
Voxelotor Sickle Cell Exercise Study